SI
Sofinnova Investments’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-203,200
| Closed | -$19.8M | – | 74 |
|
|
2021
Q2 | $19.8M | Buy |
+203,200
| New | +$19.8M | 1.14% | 22 |
|
|
2019
Q4 | – | Sell |
-191,679
| Closed | -$17.3M | – | 63 |
|
|
2019
Q3 | $17.3M | Buy |
191,679
+35,819
| +23% | +$3.23M | 1.56% | 18 |
|
|
2019
Q2 | $13.2M | Buy |
155,860
+43,454
| +39% | +$3.67M | 1.21% | 18 |
|
|
2019
Q1 | $9.9M | Buy |
112,406
+50,906
| +83% | +$4.49M | 0.95% | 20 |
|
|
2018
Q4 | $4.39M | Buy |
+61,500
| New | +$4.39M | 0.55% | 35 |
|